Ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma: extended 3.5-year follow-up from a pooled analysis

出版年份 2018 全文链接

标题

作者

关键词

出版物

Volume -, Issue -, Pages haematol.2018.205229

出版商

Ferrata Storti Foundation (Haematologica)

发表日期

2018-11-16

DOI

10.3324/haematol.2018.205229

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started